57 top medical experts on 3-Hydroxyacyl-CoA Dehydrogenase Deficiency across 7 countries and 1 U.S. states, including 1 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A rare form of congenital diazoxide-sensitive diffuse hyperinsulinism due to short chain 3 hydroxylacyl-CoA dehydrogenase (SCHAD; HADH gene) deficiency and characterized by hyperinsulinemic hypoglycemia with seizures and reported to respond well to diazoxide. It presents with the classical manifestations of hyperinsulinemic hypoglycemia. Exceptional complications include sudden death, and in one case fulminant hepatic failure.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Synonyms: 3-Alpha-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency,  3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency,  HAD Deficiency,  HADH Deficiency,  HADHSC Deficiency,  Deficiency Short Chain L-3-Alpha-Hydroxyacyl-CoA Dehydrogenase,  M-SCHAD Deficiency,  SCHAD Deficiency


  

        

                    


    Computing Expert Listing ...